Randomized, double-blind, placebo-controlled, crossover study of botulinum toxin type A (Botox) for the treatment of pain associated with cervical dystonia [torticollis] and refractory cervicothoracic myofascial pain syndrome
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Myofascial pain; Torticollis
- Focus Therapeutic Use
- 16 Aug 2007 Status changed from in progress to completed.
- 18 Nov 2005 New trial record.